From: The effect of tiotropium therapy on markers of elastin degradation in COPD
PATIENTS | URINE (ug/g creatinine) | PLASMA (ng/ml) | SPUTUM (ng/ml) | ||
---|---|---|---|---|---|
 |  | FREE | F/T(%) |  |  |
-1- | 0 month 1 month 2 month | 6.57 4.99 5.29 | 49.6 48.5 38.5 | 0.42 0.37 0.47 | 0.92 0.15 0.05 |
-2- | 0 month 1 month 2 month | 9.50 5.91 7.50 | 40.8 41.9 32.7 | 0.71 0.67 0.45 | 0.77 0.19 0.33 |
-3- | 0 month 1 month 2 month | 3.90 5.37 4.45 | 35.1 38.1 39.9 | 0.71 0.54 0.33 | 0.52 0.26 0.10 |
-4- | 0 month 1 month 2 month | 5.14 4.82 6.91 | 45.0 42.3 32.5 | 0.77 0.40 0.45 | 0.33 0.23 0.18 |
-5- | 0 month 1 month 2 month | 7.54 4.95 4.68 | 46.2 51.4 47.1 | 0.73 0.57 0.55 | 0.49 0.16 0.14 |
-6- | 0 month 1 month 2 month | 3.31 3.72 3.05 | 36.2 34.2 31.4 | 0.44 0.40 0.50 | 0.05 0.01 0.03 |
-7- | 0 month 1 month 2 month | 3.40 5.38 4.79 | 40.9 40.2 37.4 | 0.62 0.63 0.61 | 0.23 0.30 0.22 |
-8- | 0 month 1 month 2 month | 3.76 3.48 3.15 | 39.4 35.3 35.0 | 0.52 0.39 0.42 | 0.27 0.29 0.13 |
-9- | 0 month 1 month 2 month | 6.61 5.26 4.71 | 63.2 43.0 39.1 | 0.51 0.64 0.46 | 0.19 0.22 0.10 |
-10- | 0 month 1 month 2 month | 7.59 5.98 4.87 | 50.7 46.6 43.9 | 0.75 0.46 0.26 | 0.19 0.12 0.06 |
-11- | 0 month 1 month 2 month | 5.67 4.71 4.97 | 51.0 45.3 40.2 | 0.61 0.38 0.33 | 0.22 0.08 0.08 |
-12- | 0 month 1 month 2 month | 5.83 5.13 5.55 | 53.4 48.9 39.7 | 0.67 0.34 0.33 | 0.52 1.07 0.13 |
Normal Subjects[5] (n-13) | 2.52 (± 0.53) | 19.0 (± 2.0) | 0.19 (= + 0,01) | none |